Four Decades for Justice
Bringing to bear “extensive trial experience across a range of complex civil disputes,” Cravath’s “[s]tandout bench of litigators” prepares each case as if it is going to trial, providing a strategic advantage in all steps of litigation. (Chambers USA) We work from day one to tell our client’s story, and our adversaries know that, when necessary, we have the experience and determination to take even the most difficult or uncharted cases to verdict.
Demonstrating our grit, ingenuity and unparalleled skill at trial, Cravath has “repeatedly gone the distance in some of the thorniest, most complex trials and appeals” in the last several years, and we are regularly hired as new counsel on matters when it becomes clear they are likely to go to trial. (The American Lawyer) Our deep bench of trial-ready attorneys has tried numerous high‑impact, business‑critical cases spanning every major practice area—including antitrust, general commercial, intellectual property, M&A and securities—in both private actions and cases brought by the government. We have amassed a score of significant trial victories that cut to the core of our clients’ businesses, advancing the front lines of law and innovation in the process. From seeking to accelerate the widespread adoption of a life‑saving cancer test, to defending a plan for a clean energy future, to shaping the bounds of antitrust law in the technology sector, we consistently push past the playbook to deliver the best results for our clients.
Cravath was named Benchmark Litigation’s 2021 “Trial Firm of the Year,” in addition to being repeatedly ranked by the publication as a “Top 20 Trial Law Firm.” We also were named New York Law Journal’s “Litigation Department of the Year” in 2022 and 2019, and the Firm’s litigators are regularly recognized as leading trial lawyers by Benchmark, Chambers USA and The Legal 500 US.
We have earned repeated praise from clients and the market, including:
Demonstrating our grit, ingenuity and unparalleled skill at trial, Cravath has “repeatedly gone the distance in some of the thorniest, most complex trials and appeals” in the last several years, and we are regularly hired as new counsel on matters when it becomes clear they are likely to go to trial. (The American Lawyer) Our deep bench of trial-ready attorneys has tried numerous high‑impact, business‑critical cases spanning every major practice area—including antitrust, general commercial, intellectual property, M&A and securities—in both private actions and cases brought by the government. We have amassed a score of significant trial victories that cut to the core of our clients’ businesses, advancing the front lines of law and innovation in the process. From seeking to accelerate the widespread adoption of a life‑saving cancer test, to defending a plan for a clean energy future, to shaping the bounds of antitrust law in the technology sector, we consistently push past the playbook to deliver the best results for our clients.
Cravath was named Benchmark Litigation’s 2021 “Trial Firm of the Year,” in addition to being repeatedly ranked by the publication as a “Top 20 Trial Law Firm.” We also were named New York Law Journal’s “Litigation Department of the Year” in 2022 and 2019, and the Firm’s litigators are regularly recognized as leading trial lawyers by Benchmark, Chambers USA and The Legal 500 US.
We have earned repeated praise from clients and the market, including:
Deals & Cases
July 14, 2023
On July 13, 2023, a three judge panel for the U.S. Court of Appeals for the Third Circuit ruled in favor of Cravath clients Louis Dreyfus Company LLC (“LDC”) and Imperial Sugar Company (“Imperial Sugar”) and unanimously affirmed an earlier decision by the U.S. District Court for the District of Delaware denying U.S. Department of Justice’s (“DOJ”) request for an injunction to block LDC’s sale of the assets and business of Imperial Sugar to U.S. Sugar.
Deals & Cases
June 09, 2023
On June 6, 2023, the Delaware Supreme Court affirmed the Delaware Court of Chancery’s judgment in favor of Cravath client Elon Musk on all counts in a stockholder derivative suit related to Tesla, Inc.’s (“Tesla”) 2016 acquisition of SolarCity Corp. (“SolarCity”).
Deals & Cases
September 23, 2022
On September 23, 2022, the U.S. District Court for the District of Delaware denied the U.S. Department of Justice’s request for an injunction blocking Louis Dreyfus Company LLC’s (“LDC”) sale of the assets and business of its subsidiary Imperial Sugar Company (“Imperial Sugar”) to U.S. Sugar. The District of Delaware’s decision in favor of the Defendants followed a four day trial in April 2022 and post-trial briefing submitted in May 2022.
Deals & Cases
September 02, 2022
On September 1, 2022, Chief Administrative Law Judge D. Michael Chappell of the Federal Trade Commission (“FTC”) ruled in favor of Cravath client Illumina, rejecting the FTC’s challenge to Illumina’s $8 billion acquisition of GRAIL, which closed in August 2021.
Deals & Cases
August 29, 2022
On August 25, 2022, the Delaware Court of Chancery granted in full Cravath client The Williams Companies, Inc.’s (“Williams”) motion for interest, attorneys’ fees and expenses, totaling more than $185 million at the time the motion was taken under submission. The decision followed post‑trial discovery, briefing and oral argument between January and May 2022.
Accolades
September 11, 2023
On September 8, 2023, Lawdragon announced the inclusion of 38 Cravath partners in its second edition list of the “500 Leading Litigators in America.” The list, assembled based on research and vetting by peers, recognizes the “array of talent in America’s great trial teams” who represent entities in cases spanning the areas of antitrust, finance, government investigations, intellectual property, M&A and securities, among many others.
Activities & Publications
July 31, 2023
On July 31, 2023, Cravath published the latest edition of its Quarterly Review, which examines the Q2 2023 M&A, activism and corporate governance landscape. The Review provides an overview of activity in those areas, highlights notable cases in the M&A space, shares trends in activism activity and notes key developments in corporate governance over the second quarter of 2023. This edition also examines the Federal Trade Commission and Department of Justice’s proposed changes to the merger guidelines and other antitrust enforcement and policy developments, alongside recent Delaware cases and pronouncements related to corporate governance matters.
Activities & Publications
April 28, 2023
On April 28, 2023, Cravath published the latest edition of its Quarterly Review, which examines the Q1 2023 M&A, activism and corporate governance landscape. The Review provides an overview of activity in those areas, highlights notable cases in the M&A space, shares trends in activism activity and notes key developments in corporate governance over the first quarter of 2023. This edition also examines other first‑quarter highlights, including the first Delaware judicial decision to hold that non‑director corporate officers owe stockholders a fiduciary duty of oversight, recent antitrust policy developments and enforcement actions, the continuing increase in global activist activity and recent pronouncements related to corporate governance matters.
Accolades
March 17, 2023
On March 15, 2023, Benchmark Litigation honored Cravath at the publication’s eleventh annual U.S. Awards, which was held in New York City in celebration of “the country’s most distinguished litigators and their firms for their exemplary work over the past twelve months.” The Firm was awarded Benchmark Litigation’s “Antitrust Firm of the Year” award, which recognized Cravath’s representation of clients, including Epic Games, Louis Dreyfus Company and Qualcomm. Cravath partner Timothy G. Cameron accepted the award on behalf of the Firm.
Accolades
February 13, 2023
On February 9, 2023, Cravath was featured by Law360 as a “Competition Practice Group of the Year,” receiving the distinction for the fifth time in six years. The profile recognized the Firm’s role in securing “major trial wins” for clients Louis Dreyfus Company in the denial of the DOJ’s request for an injunction to block its sale of Imperial Sugar Company, and Illumina in a groundbreaking victory rejecting the FTC’s challenge to its $8 billion acquisition of GRAIL, as well as obtaining a “crucial ruling” for Blue Cross Blue Shield (“BCBS”) on a summary judgment motion in long‑running antitrust litigation.
Deals & Cases
July 14, 2023
On July 13, 2023, a three judge panel for the U.S. Court of Appeals for the Third Circuit ruled in favor of Cravath clients Louis Dreyfus Company LLC (“LDC”) and Imperial Sugar Company (“Imperial Sugar”) and unanimously affirmed an earlier decision by the U.S. District Court for the District of Delaware denying U.S. Department of Justice’s (“DOJ”) request for an injunction to block LDC’s sale of the assets and business of Imperial Sugar to U.S. Sugar.
Deals & Cases
June 09, 2023
On June 6, 2023, the Delaware Supreme Court affirmed the Delaware Court of Chancery’s judgment in favor of Cravath client Elon Musk on all counts in a stockholder derivative suit related to Tesla, Inc.’s (“Tesla”) 2016 acquisition of SolarCity Corp. (“SolarCity”).
Deals & Cases
September 23, 2022
On September 23, 2022, the U.S. District Court for the District of Delaware denied the U.S. Department of Justice’s request for an injunction blocking Louis Dreyfus Company LLC’s (“LDC”) sale of the assets and business of its subsidiary Imperial Sugar Company (“Imperial Sugar”) to U.S. Sugar. The District of Delaware’s decision in favor of the Defendants followed a four day trial in April 2022 and post-trial briefing submitted in May 2022.
Deals & Cases
September 02, 2022
On September 1, 2022, Chief Administrative Law Judge D. Michael Chappell of the Federal Trade Commission (“FTC”) ruled in favor of Cravath client Illumina, rejecting the FTC’s challenge to Illumina’s $8 billion acquisition of GRAIL, which closed in August 2021.
Deals & Cases
August 29, 2022
On August 25, 2022, the Delaware Court of Chancery granted in full Cravath client The Williams Companies, Inc.’s (“Williams”) motion for interest, attorneys’ fees and expenses, totaling more than $185 million at the time the motion was taken under submission. The decision followed post‑trial discovery, briefing and oral argument between January and May 2022.
Accolades
September 11, 2023
On September 8, 2023, Lawdragon announced the inclusion of 38 Cravath partners in its second edition list of the “500 Leading Litigators in America.” The list, assembled based on research and vetting by peers, recognizes the “array of talent in America’s great trial teams” who represent entities in cases spanning the areas of antitrust, finance, government investigations, intellectual property, M&A and securities, among many others.
Activities & Publications
July 31, 2023
On July 31, 2023, Cravath published the latest edition of its Quarterly Review, which examines the Q2 2023 M&A, activism and corporate governance landscape. The Review provides an overview of activity in those areas, highlights notable cases in the M&A space, shares trends in activism activity and notes key developments in corporate governance over the second quarter of 2023. This edition also examines the Federal Trade Commission and Department of Justice’s proposed changes to the merger guidelines and other antitrust enforcement and policy developments, alongside recent Delaware cases and pronouncements related to corporate governance matters.
Activities & Publications
April 28, 2023
On April 28, 2023, Cravath published the latest edition of its Quarterly Review, which examines the Q1 2023 M&A, activism and corporate governance landscape. The Review provides an overview of activity in those areas, highlights notable cases in the M&A space, shares trends in activism activity and notes key developments in corporate governance over the first quarter of 2023. This edition also examines other first‑quarter highlights, including the first Delaware judicial decision to hold that non‑director corporate officers owe stockholders a fiduciary duty of oversight, recent antitrust policy developments and enforcement actions, the continuing increase in global activist activity and recent pronouncements related to corporate governance matters.
Accolades
March 17, 2023
On March 15, 2023, Benchmark Litigation honored Cravath at the publication’s eleventh annual U.S. Awards, which was held in New York City in celebration of “the country’s most distinguished litigators and their firms for their exemplary work over the past twelve months.” The Firm was awarded Benchmark Litigation’s “Antitrust Firm of the Year” award, which recognized Cravath’s representation of clients, including Epic Games, Louis Dreyfus Company and Qualcomm. Cravath partner Timothy G. Cameron accepted the award on behalf of the Firm.
Accolades
February 13, 2023
On February 9, 2023, Cravath was featured by Law360 as a “Competition Practice Group of the Year,” receiving the distinction for the fifth time in six years. The profile recognized the Firm’s role in securing “major trial wins” for clients Louis Dreyfus Company in the denial of the DOJ’s request for an injunction to block its sale of Imperial Sugar Company, and Illumina in a groundbreaking victory rejecting the FTC’s challenge to its $8 billion acquisition of GRAIL, as well as obtaining a “crucial ruling” for Blue Cross Blue Shield (“BCBS”) on a summary judgment motion in long‑running antitrust litigation.
Explore
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. © 2023 Cravath, Swaine & Moore LLP.